Company Filing History:
Years Active: 2020
Title: David C Bulir: Innovator in Chlamydial Infection Research
Introduction
David C Bulir is a notable inventor based in Hamilton, Canada. He has made significant contributions to the field of medical research, particularly in the treatment and prevention of chlamydial infections. His work has implications for improving health outcomes in affected populations.
Latest Patents
David C Bulir holds a patent for "Type III secretion injectisome proteins for treatment and prevention of chlamydial infections." This patent includes the Cpn0803, CopB (Cpn0809), and CopD (Cpn0808) proteins, which are shown to induce an immune response that is protective against live challenges with chlamydia. The methods and uses of Cpn0803, or fragments or epitopes thereof, alone or in combination with CopB and/or CopD, provide innovative approaches for treating or preventing chlamydial infections in subjects in need.
Career Highlights
David C Bulir is affiliated with McMaster University, where he conducts his research. His work has garnered attention for its potential to advance the understanding and treatment of chlamydial infections. He has been recognized for his contributions to the field, which reflect his dedication to improving public health.
Collaborations
David collaborates with esteemed colleagues, including James B Mahony and Christopher B Stone. These partnerships enhance the research efforts and contribute to the development of effective treatments for chlamydial infections.
Conclusion
David C Bulir's innovative work in the field of chlamydial infection research exemplifies the impact of dedicated inventors in advancing medical science. His contributions are vital for developing new strategies to combat this prevalent infection.